Announcements Trials
Browse Landscape

Phase

Phase 3 2Phase 2 1Phase 1 1

Status

Terminated 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Lymphoma 113Leukemia 80Precursor Cell Lymphoblastic Leukemia-Lymphoma 61Lymphoma, Non-Hodgkin 59Multiple Myeloma 56Leukemia, Myeloid, Acute 56Lymphoma, Large B-Cell, Diffuse 55Hodgkin Disease 48Myelodysplastic Syndromes 43Burkitt Lymphoma 43Lymphoma, Follicular 41Leukemia, Lymphocytic, Chronic, B-Cell 41Lymphoma, Mantle-Cell 40Breast Neoplasms 35Lymphoma, Large-Cell, Immunoblastic 34Sarcoma 27Neoplasms, Plasma Cell 27Central Nervous System Neoplasms 25Lymphoma, B-Cell, Marginal Zone 24Dendritic Cell Sarcoma, Interdigitating 19Recurrence 18Leukemia, Myelogenous, Chronic, BCR-ABL Positive 18Ovarian Neoplasms 16Neuroblastoma 16Myeloproliferative Disorders 16Leukemia, Myeloid, Chronic-Phase 16Leukemia, Myeloid, Accelerated Phase 15Congenital Abnormalities 15Neutropenia 13Lung Neoplasms 13

Interventions

Doxorubicin 8Cyclophosphamide 4Docetaxel 3Atorvastatin 3dapagliflozin 2Trastuzumab 2Chemotherapy, Adjuvant 2Carvedilol 2nicotinamide-beta-riboside 1empagliflozin 1Tablets 1Reverse Transcriptase Polymerase Chain Reaction 1Radiotherapy 1Paclitaxel 1Neoadjuvant Therapy 1Methotrexate 1Metformin 1Mass Spectrometry 1Lisinopril 1Leucovorin 1Lapatinib 1Hydroxymethylglutaryl-CoA Reductase Inhibitors 1Gene Expression Profiling 1Fluorophotometry 1Filgrastim 1Fenofibrate 1Epirubicin 1Environmental Biomarkers 1Echocardiography 1Dexrazoxane 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Cardiotoxicity × Filgrastim × Clear all
NCT00019864 2015-06-08

Combination Chemotherapy Before and After Surgery in Treating Patients With Osteosarcoma

National Cancer Institute (NCI)

Phase 2 Terminated
100 enrolled
Sarcoma

Sarcoma, Osteosarcoma, Cardiotoxicity

Data powered by HemOnc (CC BY 4.0) Colophon âš¡